ClinVar Miner

Submissions for variant NM_001040142.2(SCN2A):c.2995G>A (p.Glu999Lys) (rs796053126)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000189130 SCV000242762 pathogenic not provided 2017-07-25 criteria provided, single submitter clinical testing The E999K variant has been reported previously as a de novo variant in multiple individuals with Ohtahara syndrome, early infantile epileptic encephaopathy, and severe intellectual disability (Nakamura et al., 2013, Allen et al., 2015, Trump et al., 2016). The E999K variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The E999K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution alters a conserved position in the intracellular loop between the second and third transmembrane domains (Shi et al., 2012), and other missense variants have been reported in this region of the protein in association with epilepsy. A missense change at the same codon (E999V) has been reported in association with SCN2A-related disorder (Stenson et al., 2014, Trump et al., 2016). In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, based on the currently available information, E999K is considered a pathogenic variant.
NeuroMeGen,Hospital Clinico Santiago de Compostela RCV000496128 SCV000586737 likely pathogenic Early infantile epileptic encephalopathy 11 criteria provided, single submitter clinical testing
Invitae RCV000814425 SCV000954835 pathogenic Benign familial neonatal-infantile seizures; Early infantile epileptic encephalopathy 11 2018-07-23 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid with lysine at codon 999 of the SCN2A protein (p.Glu999Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals affected with early onset epileptic encephalopathy; in many of these cases, it was observed to be de novo (PMID: 26993267, 28379373, 27867041, 26648591, 23935176). ClinVar contains an entry for this variant (Variation ID: 206981). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.